[ { "record_id": "PR-found-tirzepatide-compounded-injectable-169", "provider": "Found", "provider_slug": "found", "medication": "tirzepatide", "formulation": "compounded injectable", "program_type": "prepaid", "dose_coverage": "flat at all covered doses", "billing_term": "prepaid term", "plan_total": 169, "monthly_equivalent": 169, "membership_required": null, "consultation_fee": null, "lab_fee": null, "shipping": null, "dose_surcharge": null, "intro_or_ongoing": "ongoing", "source_url": null, "capture_date": "2026-07-06", "archive": null, "reviewer": null, "evidence_status": "reported", "evidence_id": "EV-04001", "notes": "12-month prepaid. Medication included, flat at all doses. 6-month ~$199; month-to-month $289.", "captured_by": null, "price_type": "commitment_tier", "verification_method": null, "dose_escalation_note": null, "capture_age_days": 20, "freshness": null }, { "record_id": "PR-oak-longevity-tirzepatide-withdrawn-1646", "provider": "Oak Longevity", "provider_slug": "oak-longevity", "medication": "tirzepatide", "formulation": "compounded injectable", "program_type": "prepaid", "dose_coverage": "flat at all covered doses", "billing_term": "prepaid term", "plan_total": null, "monthly_equivalent": null, "membership_required": null, "consultation_fee": null, "lab_fee": null, "shipping": null, "dose_surcharge": null, "intro_or_ongoing": "ongoing", "source_url": null, "capture_date": "2026-07-06", "archive": null, "reviewer": null, "evidence_status": "third_party", "evidence_id": "EV-04003", "notes": "Figure appeared in a third-party publication. We have not confirmed it on the provider's own site and have withdrawn it from every ranking and total until we capture it ourselves.", "captured_by": null, "price_type": "unconfirmed", "verification_method": null, "dose_escalation_note": null, "capture_age_days": 20, "freshness": null }, { "record_id": "PR-shed-tirzepatide-compounded-injectable-245", "provider": "Shed", "provider_slug": "shed", "medication": "tirzepatide", "formulation": "compounded injectable", "program_type": "prepaid", "dose_coverage": null, "billing_term": "prepaid term", "plan_total": 245, "monthly_equivalent": 245, "membership_required": null, "consultation_fee": null, "lab_fee": null, "shipping": null, "dose_surcharge": null, "intro_or_ongoing": "ongoing", "source_url": null, "capture_date": "2026-07-06", "archive": null, "reviewer": null, "evidence_status": "reported", "evidence_id": "EV-04004", "notes": "12-month plan paid upfront. 6-month $279; month-to-month $349. Increases at higher doses.", "captured_by": null, "price_type": "commitment_tier", "verification_method": null, "dose_escalation_note": null, "capture_age_days": 20, "freshness": null }, { "record_id": "PR-enhance-md-tirzepatide-compounded-injectable-280", "provider": "Enhance.MD", "provider_slug": "enhance-md", "medication": "tirzepatide", "formulation": "compounded injectable", "program_type": "prepaid", "dose_coverage": null, "billing_term": "prepaid term", "plan_total": 280, "monthly_equivalent": 280, "membership_required": null, "consultation_fee": null, "lab_fee": null, "shipping": null, "dose_surcharge": null, "intro_or_ongoing": "ongoing", "source_url": null, "capture_date": "2026-07-06", "archive": null, "reviewer": null, "evidence_status": "reported", "evidence_id": "EV-04006", "notes": "12-month plan. Same price at all doses. 6-month $296; 3-month $313; month-to-month $329.", "captured_by": null, "price_type": "commitment_tier", "verification_method": null, "dose_escalation_note": null, "capture_age_days": 20, "freshness": null }, { "record_id": "PR-eden-tirzepatide-compounded-injectable-298", "provider": "Eden", "provider_slug": "eden", "medication": "tirzepatide", "formulation": "compounded injectable", "program_type": "month_to_month", "dose_coverage": "flat at all covered doses", "billing_term": "month-to-month", "plan_total": 298, "monthly_equivalent": 298, "membership_required": null, "consultation_fee": null, "lab_fee": null, "shipping": null, "dose_surcharge": null, "intro_or_ongoing": "ongoing", "source_url": null, "capture_date": "2026-07-06", "archive": null, "reviewer": null, "evidence_status": "reported", "evidence_id": "EV-04007", "notes": "$199 medication (flat at every dose) + $99 membership, required.", "captured_by": null, "price_type": "recurring", "verification_method": null, "dose_escalation_note": null, "capture_age_days": 20, "freshness": null }, { "record_id": "PR-noom-med-tirzepatide-compounded-injectable-299", "provider": "Noom Med", "provider_slug": "noom-med", "medication": "tirzepatide", "formulation": "compounded injectable", "program_type": "prepaid", "dose_coverage": null, "billing_term": "prepaid term", "plan_total": 299, "monthly_equivalent": 299, "membership_required": null, "consultation_fee": null, "lab_fee": null, "shipping": null, "dose_surcharge": null, "intro_or_ongoing": "ongoing", "source_url": null, "capture_date": "2026-07-06", "archive": null, "reviewer": null, "evidence_status": "reported", "evidence_id": "EV-04008", "notes": "Full dose. First month $149. Billed quarterly.", "captured_by": null, "price_type": "commitment_tier", "verification_method": null, "dose_escalation_note": null, "capture_age_days": 20, "freshness": null }, { "record_id": "PR-trimrx-tirzepatide-compounded-injectable-349", "provider": "TrimRx", "provider_slug": "trimrx", "medication": "tirzepatide", "formulation": "compounded injectable", "program_type": "month_to_month", "dose_coverage": "flat at all covered doses", "billing_term": "month-to-month", "plan_total": 349, "monthly_equivalent": 349, "membership_required": 0, "consultation_fee": null, "lab_fee": null, "shipping": null, "dose_surcharge": null, "intro_or_ongoing": "ongoing", "source_url": null, "capture_date": "2026-07-06", "archive": null, "reviewer": null, "evidence_status": "reported", "evidence_id": "EV-04009", "notes": "Flat rate, all doses, no membership. Month-to-month $279 first month then $399. Prepay $316 (3-mo), $299 (6-mo), $283 (12-mo).", "captured_by": null, "price_type": "recurring", "verification_method": null, "dose_escalation_note": null, "capture_age_days": 20, "freshness": null }, { "record_id": "PR-medvi-tirzepatide-compounded-injectable-399", "provider": "MEDVi", "provider_slug": "medvi", "medication": "tirzepatide", "formulation": "compounded injectable", "program_type": "month_to_month", "dose_coverage": null, "billing_term": "month-to-month", "plan_total": null, "monthly_equivalent": null, "membership_required": null, "consultation_fee": null, "lab_fee": null, "shipping": null, "dose_surcharge": null, "intro_or_ongoing": "ongoing", "source_url": null, "capture_date": null, "archive": null, "reviewer": null, "evidence_status": "third_party", "evidence_id": "EV-04010", "notes": "This provider is in our comparison set but we hold no pricing for it. It publishes no public figure we could read, or gates pricing behind an intake. We record the absence rather than estimating.", "captured_by": null, "price_type": "recurring", "verification_method": null, "dose_escalation_note": null, "capture_age_days": null, "freshness": null }, { "record_id": "PR-bmimd-tirzepatide-compounded-injectable-399", "provider": "bmiMD", "provider_slug": "bmimd", "medication": "tirzepatide", "formulation": "compounded injectable", "program_type": "month_to_month", "dose_coverage": null, "billing_term": "month-to-month", "plan_total": 399, "monthly_equivalent": 399, "membership_required": null, "consultation_fee": null, "lab_fee": null, "shipping": null, "dose_surcharge": null, "intro_or_ongoing": "ongoing", "source_url": null, "capture_date": "2026-07-06", "archive": null, "reviewer": null, "evidence_status": "reported", "evidence_id": "EV-04011", "notes": "All-inclusive. Micro-dose $349.", "captured_by": null, "price_type": "recurring", "verification_method": null, "dose_escalation_note": null, "capture_age_days": 20, "freshness": null }, { "record_id": "PR-enhance-md-tirzepatide-compounded-microdose-169", "provider": "Enhance.MD", "provider_slug": "enhance-md", "medication": "tirzepatide", "formulation": "compounded microdose", "program_type": "prepaid", "dose_coverage": null, "billing_term": "prepaid term", "plan_total": 169, "monthly_equivalent": 169, "membership_required": null, "consultation_fee": null, "lab_fee": null, "shipping": null, "dose_surcharge": null, "intro_or_ongoing": "ongoing", "source_url": null, "capture_date": "2026-07-06", "archive": null, "reviewer": null, "evidence_status": "reported", "evidence_id": "EV-04013", "notes": "Microdose, 1 mg/week. Delivery every 12 weeks. Includes medication, care, lab testing, shipping.", "captured_by": null, "price_type": "commitment_tier", "verification_method": null, "dose_escalation_note": null, "capture_age_days": 20, "freshness": null }, { "record_id": "PR-shed-tirzepatide-compounded-microdose-199", "provider": "Shed", "provider_slug": "shed", "medication": "tirzepatide", "formulation": "compounded microdose", "program_type": "prepaid", "dose_coverage": null, "billing_term": "prepaid term", "plan_total": 199, "monthly_equivalent": 199, "membership_required": null, "consultation_fee": null, "lab_fee": null, "shipping": null, "dose_surcharge": null, "intro_or_ongoing": "ongoing", "source_url": null, "capture_date": "2026-07-06", "archive": null, "reviewer": null, "evidence_status": "reported", "evidence_id": "EV-04014", "notes": "Microdose programme. Two-month minimum.", "captured_by": null, "price_type": "commitment_tier", "verification_method": null, "dose_escalation_note": null, "capture_age_days": 20, "freshness": null }, { "record_id": "PR-bmimd-tirzepatide-compounded-microdose-349", "provider": "bmiMD", "provider_slug": "bmimd", "medication": "tirzepatide", "formulation": "compounded microdose", "program_type": "month_to_month", "dose_coverage": null, "billing_term": "month-to-month", "plan_total": 349, "monthly_equivalent": 349, "membership_required": null, "consultation_fee": null, "lab_fee": null, "shipping": null, "dose_surcharge": null, "intro_or_ongoing": "ongoing", "source_url": null, "capture_date": "2026-07-06", "archive": null, "reviewer": null, "evidence_status": "reported", "evidence_id": "EV-04015", "notes": "Tirzepatide micro-dose.", "captured_by": null, "price_type": "recurring", "verification_method": null, "dose_escalation_note": null, "capture_age_days": 20, "freshness": null }, { "record_id": "PR-henry-meds-tirzepatide-withdrawn-6695", "provider": "Henry Meds", "provider_slug": "henry-meds", "medication": "tirzepatide", "formulation": "compounded oral / ODT", "program_type": "prepaid", "dose_coverage": null, "billing_term": "prepaid term", "plan_total": null, "monthly_equivalent": null, "membership_required": null, "consultation_fee": null, "lab_fee": null, "shipping": null, "dose_surcharge": null, "intro_or_ongoing": "ongoing", "source_url": null, "capture_date": "2026-07-06", "archive": null, "reviewer": null, "evidence_status": "third_party", "evidence_id": "EV-04017", "notes": "The $179 figure was reported by four publications as a flat tirzepatide rate. Sources that checked report it applies to liraglutide or a 12-month prepay, that injectable pricing is materially higher, and that doses escalate by about $100 per tier. Withdrawn; see COR-009.", "captured_by": null, "price_type": "unconfirmed", "verification_method": null, "dose_escalation_note": null, "capture_age_days": 20, "freshness": null }, { "record_id": "PR-shed-semaglutide-compounded-microdose-149", "provider": "Shed", "provider_slug": "shed", "medication": "semaglutide", "formulation": "compounded microdose", "program_type": "prepaid", "dose_coverage": null, "billing_term": "prepaid term", "plan_total": 149, "monthly_equivalent": 149, "membership_required": null, "consultation_fee": null, "lab_fee": null, "shipping": null, "dose_surcharge": null, "intro_or_ongoing": "ongoing", "source_url": null, "capture_date": "2026-07-06", "archive": null, "reviewer": null, "evidence_status": "reported", "evidence_id": "EV-04019", "notes": "Microdose programme. Two-month minimum.", "captured_by": null, "price_type": "commitment_tier", "verification_method": null, "dose_escalation_note": null, "capture_age_days": 20, "freshness": null }, { "record_id": "PR-oak-longevity-semaglutide-withdrawn-1646", "provider": "Oak Longevity", "provider_slug": "oak-longevity", "medication": "semaglutide", "formulation": "compounded injectable", "program_type": "prepaid", "dose_coverage": "flat at all covered doses", "billing_term": "prepaid term", "plan_total": null, "monthly_equivalent": null, "membership_required": null, "consultation_fee": null, "lab_fee": null, "shipping": null, "dose_surcharge": null, "intro_or_ongoing": "ongoing", "source_url": null, "capture_date": "2026-07-06", "archive": null, "reviewer": null, "evidence_status": "third_party", "evidence_id": "EV-04020", "notes": "Figure appeared in a third-party publication. We have not confirmed it on the provider's own site and have withdrawn it from every ranking and total until we capture it ourselves.", "captured_by": null, "price_type": "unconfirmed", "verification_method": null, "dose_escalation_note": null, "capture_age_days": 20, "freshness": null }, { "record_id": "PR-found-semaglutide-compounded-injectable-169", "provider": "Found", "provider_slug": "found", "medication": "semaglutide", "formulation": "compounded injectable", "program_type": "prepaid", "dose_coverage": "flat at all covered doses", "billing_term": "prepaid term", "plan_total": 169, "monthly_equivalent": 169, "membership_required": null, "consultation_fee": null, "lab_fee": null, "shipping": null, "dose_surcharge": null, "intro_or_ongoing": "ongoing", "source_url": null, "capture_date": "2026-07-06", "archive": null, "reviewer": null, "evidence_status": "reported", "evidence_id": "EV-04022", "notes": "12-month prepaid. Medication included, flat across all compounded GLP-1s and all doses. 6-month ~$199; month-to-month $289.", "captured_by": null, "price_type": "commitment_tier", "verification_method": null, "dose_escalation_note": null, "capture_age_days": 20, "freshness": null }, { "record_id": "PR-shed-semaglutide-compounded-injectable-175", "provider": "Shed", "provider_slug": "shed", "medication": "semaglutide", "formulation": "compounded injectable", "program_type": "prepaid", "dose_coverage": null, "billing_term": "prepaid term", "plan_total": 175, "monthly_equivalent": 175, "membership_required": null, "consultation_fee": null, "lab_fee": null, "shipping": null, "dose_surcharge": null, "intro_or_ongoing": "ongoing", "source_url": null, "capture_date": "2026-07-06", "archive": null, "reviewer": null, "evidence_status": "reported", "evidence_id": "EV-04023", "notes": "12-month plan paid upfront. 6-month $199; month-to-month $249. Increases at higher doses.", "captured_by": null, "price_type": "commitment_tier", "verification_method": null, "dose_escalation_note": null, "capture_age_days": 20, "freshness": null }, { "record_id": "PR-eden-semaglutide-compounded-injectable-198", "provider": "Eden", "provider_slug": "eden", "medication": "semaglutide", "formulation": "compounded injectable", "program_type": "month_to_month", "dose_coverage": "flat at all covered doses", "billing_term": "month-to-month", "plan_total": 198, "monthly_equivalent": 198, "membership_required": null, "consultation_fee": null, "lab_fee": null, "shipping": null, "dose_surcharge": null, "intro_or_ongoing": "ongoing", "source_url": null, "capture_date": "2026-07-06", "archive": null, "reviewer": null, "evidence_status": "reported", "evidence_id": "EV-04025", "notes": "$99 medication (flat at every dose) + $99 membership, required for any medication.", "captured_by": null, "price_type": "recurring", "verification_method": null, "dose_escalation_note": null, "capture_age_days": 20, "freshness": null }, { "record_id": "PR-noom-med-semaglutide-compounded-injectable-199", "provider": "Noom Med", "provider_slug": "noom-med", "medication": "semaglutide", "formulation": "compounded injectable", "program_type": "prepaid", "dose_coverage": null, "billing_term": "prepaid term", "plan_total": 199, "monthly_equivalent": 199, "membership_required": null, "consultation_fee": null, "lab_fee": null, "shipping": null, "dose_surcharge": null, "intro_or_ongoing": "ongoing", "source_url": null, "capture_date": "2026-07-06", "archive": null, "reviewer": null, "evidence_status": "reported", "evidence_id": "EV-04026", "notes": "Capped at 0.6 mg maximum dose, below the 2.4 mg used in the STEP trials. Billed quarterly. Full-titration programme is $279.", "captured_by": null, "price_type": "commitment_tier", "verification_method": null, "dose_escalation_note": null, "capture_age_days": 20, "freshness": null }, { "record_id": "PR-trimrx-semaglutide-compounded-injectable-199", "provider": "TrimRx", "provider_slug": "trimrx", "medication": "semaglutide", "formulation": "compounded injectable", "program_type": "month_to_month", "dose_coverage": "flat at all covered doses", "billing_term": "month-to-month", "plan_total": 199, "monthly_equivalent": 199, "membership_required": 0, "consultation_fee": null, "lab_fee": null, "shipping": null, "dose_surcharge": null, "intro_or_ongoing": "ongoing", "source_url": null, "capture_date": "2026-07-06", "archive": null, "reviewer": null, "evidence_status": "reported", "evidence_id": "EV-04027", "notes": "Flat rate, all doses, no membership. Month-to-month $179 first month then $299. Prepay $209 (3-mo), $191 (6-mo), $174 (12-mo).", "captured_by": null, "price_type": "recurring", "verification_method": null, "dose_escalation_note": null, "capture_age_days": 20, "freshness": null }, { "record_id": "PR-enhance-md-semaglutide-compounded-injectable-212", "provider": "Enhance.MD", "provider_slug": "enhance-md", "medication": "semaglutide", "formulation": "compounded injectable", "program_type": "prepaid", "dose_coverage": null, "billing_term": "prepaid term", "plan_total": 212, "monthly_equivalent": 212, "membership_required": null, "consultation_fee": null, "lab_fee": null, "shipping": null, "dose_surcharge": null, "intro_or_ongoing": "ongoing", "source_url": null, "capture_date": "2026-07-06", "archive": null, "reviewer": null, "evidence_status": "reported", "evidence_id": "EV-04028", "notes": "12-month plan. Same price at all doses. 6-month $224; 3-month $237; month-to-month $249.", "captured_by": null, "price_type": "commitment_tier", "verification_method": null, "dose_escalation_note": null, "capture_age_days": 20, "freshness": null }, { "record_id": "PR-bmimd-semaglutide-compounded-injectable-289", "provider": "bmiMD", "provider_slug": "bmimd", "medication": "semaglutide", "formulation": "compounded injectable", "program_type": "month_to_month", "dose_coverage": null, "billing_term": "month-to-month", "plan_total": 289, "monthly_equivalent": 289, "membership_required": null, "consultation_fee": null, "lab_fee": null, "shipping": null, "dose_surcharge": null, "intro_or_ongoing": "ongoing", "source_url": null, "capture_date": "2026-07-06", "archive": null, "reviewer": null, "evidence_status": "reported", "evidence_id": "EV-04029", "notes": "All-inclusive. California and North Carolina residents $379.99. Micro-dose same price.", "captured_by": null, "price_type": "recurring", "verification_method": null, "dose_escalation_note": null, "capture_age_days": 20, "freshness": null }, { "record_id": "PR-henry-meds-semaglutide-withdrawn-1646", "provider": "Henry Meds", "provider_slug": "henry-meds", "medication": "semaglutide", "formulation": "compounded injectable", "program_type": "month_to_month", "dose_coverage": null, "billing_term": "month-to-month", "plan_total": null, "monthly_equivalent": null, "membership_required": null, "consultation_fee": null, "lab_fee": null, "shipping": null, "dose_surcharge": null, "intro_or_ongoing": "ongoing", "source_url": null, "capture_date": "2026-07-06", "archive": null, "reviewer": null, "evidence_status": "third_party", "evidence_id": "EV-04030", "notes": "The $179 figure was reported by four publications as a flat tirzepatide rate. Sources that checked report it applies to liraglutide or a 12-month prepay, that injectable pricing is materially higher, and that doses escalate by about $100 per tier. Withdrawn; see COR-009.", "captured_by": null, "price_type": "unconfirmed", "verification_method": null, "dose_escalation_note": null, "capture_age_days": 20, "freshness": null }, { "record_id": "PR-medvi-semaglutide-compounded-injectable-299", "provider": "MEDVi", "provider_slug": "medvi", "medication": "semaglutide", "formulation": "compounded injectable", "program_type": "month_to_month", "dose_coverage": null, "billing_term": "month-to-month", "plan_total": 299, "monthly_equivalent": 299, "membership_required": null, "consultation_fee": null, "lab_fee": null, "shipping": null, "dose_surcharge": null, "intro_or_ongoing": "ongoing", "source_url": null, "capture_date": "2026-07-06", "archive": null, "reviewer": null, "evidence_status": "reported", "evidence_id": "EV-04031", "notes": "Refill rate, locked in. First month $179.", "captured_by": null, "price_type": "recurring", "verification_method": null, "dose_escalation_note": null, "capture_age_days": 20, "freshness": null }, { "record_id": "PR-henry-meds-semaglutide-withdrawn-1763", "provider": "Henry Meds", "provider_slug": "henry-meds", "medication": "semaglutide", "formulation": "compounded sublingual", "program_type": "month_to_month", "dose_coverage": null, "billing_term": "month-to-month", "plan_total": null, "monthly_equivalent": null, "membership_required": null, "consultation_fee": null, "lab_fee": null, "shipping": null, "dose_surcharge": null, "intro_or_ongoing": "ongoing", "source_url": null, "capture_date": "2026-07-06", "archive": null, "reviewer": null, "evidence_status": "third_party", "evidence_id": "EV-04033", "notes": "The $179 figure was reported by four publications as a flat tirzepatide rate. Sources that checked report it applies to liraglutide or a 12-month prepay, that injectable pricing is materially higher, and that doses escalate by about $100 per tier. Withdrawn; see COR-009.", "captured_by": null, "price_type": "unconfirmed", "verification_method": null, "dose_escalation_note": null, "capture_age_days": 20, "freshness": null }, { "record_id": "PR-shed-semaglutide-compounded-sublingual-199", "provider": "Shed", "provider_slug": "shed", "medication": "semaglutide", "formulation": "compounded sublingual", "program_type": "month_to_month", "dose_coverage": null, "billing_term": "month-to-month", "plan_total": 199, "monthly_equivalent": 199, "membership_required": null, "consultation_fee": null, "lab_fee": null, "shipping": null, "dose_surcharge": null, "intro_or_ongoing": "ongoing", "source_url": null, "capture_date": "2026-07-06", "archive": null, "reviewer": null, "evidence_status": "reported", "evidence_id": "EV-04034", "notes": "Daily dissolvable lozenges, month-to-month, medication and supplies included.", "captured_by": null, "price_type": "recurring", "verification_method": null, "dose_escalation_note": null, "capture_age_days": 20, "freshness": null }, { "record_id": "PR-shed-semaglutide-compounded-sublingual-229", "provider": "Shed", "provider_slug": "shed", "medication": "semaglutide", "formulation": "compounded sublingual", "program_type": "prepaid", "dose_coverage": null, "billing_term": "prepaid term", "plan_total": 229, "monthly_equivalent": 229, "membership_required": null, "consultation_fee": null, "lab_fee": null, "shipping": null, "dose_surcharge": null, "intro_or_ongoing": "ongoing", "source_url": null, "capture_date": "2026-07-06", "archive": null, "reviewer": null, "evidence_status": "reported", "evidence_id": "EV-04035", "notes": "GLP-1 liquid drops, medication and supplies included. Two-month minimum.", "captured_by": null, "price_type": "commitment_tier", "verification_method": null, "dose_escalation_note": null, "capture_age_days": 20, "freshness": null }, { "record_id": "PR-henry-meds-semaglutide-withdrawn-6695", "provider": "Henry Meds", "provider_slug": "henry-meds", "medication": "semaglutide", "formulation": "compounded oral / ODT", "program_type": "prepaid", "dose_coverage": null, "billing_term": "prepaid term", "plan_total": null, "monthly_equivalent": null, "membership_required": null, "consultation_fee": null, "lab_fee": null, "shipping": null, "dose_surcharge": null, "intro_or_ongoing": "ongoing", "source_url": null, "capture_date": "2026-07-06", "archive": null, "reviewer": null, "evidence_status": "third_party", "evidence_id": "EV-04036", "notes": "The $179 figure was reported by four publications as a flat tirzepatide rate. Sources that checked report it applies to liraglutide or a 12-month prepay, that injectable pricing is materially higher, and that doses escalate by about $100 per tier. Withdrawn; see COR-009.", "captured_by": null, "price_type": "unconfirmed", "verification_method": null, "dose_escalation_note": null, "capture_age_days": 20, "freshness": null }, { "record_id": "PR-medvi-semaglutide-compounded-oral--ODT-369", "provider": "MEDVi", "provider_slug": "medvi", "medication": "semaglutide", "formulation": "compounded oral / ODT", "program_type": "month_to_month", "dose_coverage": null, "billing_term": "month-to-month", "plan_total": null, "monthly_equivalent": null, "membership_required": null, "consultation_fee": null, "lab_fee": null, "shipping": null, "dose_surcharge": null, "intro_or_ongoing": "ongoing", "source_url": null, "capture_date": null, "archive": null, "reviewer": null, "evidence_status": "third_party", "evidence_id": "EV-04037", "notes": "This provider is in our comparison set but we hold no pricing for it. It publishes no public figure we could read, or gates pricing behind an intake. We record the absence rather than estimating.", "captured_by": null, "price_type": "recurring", "verification_method": null, "dose_escalation_note": null, "capture_age_days": null, "freshness": null }, { "record_id": "PR-found-liraglutide-compounded-injectable-169", "provider": "Found", "provider_slug": "found", "medication": "liraglutide", "formulation": "compounded injectable", "program_type": "prepaid", "dose_coverage": "flat at all covered doses", "billing_term": "prepaid term", "plan_total": 169, "monthly_equivalent": 169, "membership_required": null, "consultation_fee": null, "lab_fee": null, "shipping": null, "dose_surcharge": null, "intro_or_ongoing": "ongoing", "source_url": null, "capture_date": "2026-07-06", "archive": null, "reviewer": null, "evidence_status": "reported", "evidence_id": "EV-04038", "notes": "Daily injection. 12-month prepaid, medication included, flat across all compounded GLP-1s.", "captured_by": null, "price_type": "commitment_tier", "verification_method": null, "dose_escalation_note": null, "capture_age_days": 20, "freshness": null }, { "record_id": "PR-henry-meds-liraglutide-withdrawn-1646", "provider": "Henry Meds", "provider_slug": "henry-meds", "medication": "liraglutide", "formulation": "compounded injectable", "program_type": "month_to_month", "dose_coverage": null, "billing_term": "month-to-month", "plan_total": null, "monthly_equivalent": null, "membership_required": null, "consultation_fee": null, "lab_fee": null, "shipping": null, "dose_surcharge": null, "intro_or_ongoing": "ongoing", "source_url": null, "capture_date": "2026-07-06", "archive": null, "reviewer": null, "evidence_status": "third_party", "evidence_id": "EV-04039", "notes": "The $179 figure was reported by four publications as a flat tirzepatide rate. Sources that checked report it applies to liraglutide or a 12-month prepay, that injectable pricing is materially higher, and that doses escalate by about $100 per tier. Withdrawn; see COR-009.", "captured_by": null, "price_type": "unconfirmed", "verification_method": null, "dose_escalation_note": null, "capture_age_days": 20, "freshness": null }, { "record_id": "PR-lillydirect-orforglipron-brand-oral,-FDA-approved-149", "provider": "LillyDirect", "provider_slug": "lillydirect", "medication": "orforglipron (Foundayo)", "formulation": "brand oral, FDA-approved", "program_type": "manufacturer_direct", "dose_coverage": null, "billing_term": "manufacturer direct", "plan_total": 149, "monthly_equivalent": 149, "membership_required": null, "consultation_fee": null, "lab_fee": null, "shipping": null, "dose_surcharge": null, "intro_or_ongoing": "ongoing", "source_url": null, "capture_date": "2026-07-06", "archive": null, "reviewer": "Editorial research desk", "evidence_status": "reported", "evidence_id": "EV-04040", "notes": "0.8 mg starter, Self Pay Journey Program. Rises to $199 (2.5 mg), $299 (5.5/9 mg), $349 (14.5/17.2 mg); drops to $299 on refill within 45 days.", "captured_by": null, "demoted_reason": "Marked verified without a capture date, source URL and named reviewer", "price_type": "recurring", "verification_method": null, "dose_escalation_note": null, "capture_age_days": 20, "freshness": null }, { "record_id": "PR-novocare-semaglutide-brand-oral,-FDA-approved-149", "provider": "NovoCare Pharmacy", "provider_slug": "novocare", "medication": "semaglutide (Wegovy tablets)", "formulation": "brand oral, FDA-approved", "program_type": "manufacturer_direct", "dose_coverage": null, "billing_term": "manufacturer direct", "plan_total": 149, "monthly_equivalent": 149, "membership_required": null, "consultation_fee": null, "lab_fee": null, "shipping": null, "dose_surcharge": null, "intro_or_ongoing": "ongoing", "source_url": null, "capture_date": "2026-07-06", "archive": null, "reviewer": "Editorial research desk", "evidence_status": "reported", "evidence_id": "EV-04041", "notes": "Wegovy tablets, 1.5 mg and 4 mg.", "captured_by": null, "demoted_reason": "Marked verified without a capture date, source URL and named reviewer", "price_type": "recurring", "verification_method": null, "dose_escalation_note": null, "capture_age_days": 20, "freshness": null }, { "record_id": "PR-lillydirect-tirzepatide-brand-injectable,-FDA-approved-299", "provider": "LillyDirect", "provider_slug": "lillydirect", "medication": "tirzepatide (Zepbound)", "formulation": "brand injectable, FDA-approved", "program_type": "manufacturer_direct", "dose_coverage": null, "billing_term": "manufacturer direct", "plan_total": 299, "monthly_equivalent": 299, "membership_required": null, "consultation_fee": null, "lab_fee": null, "shipping": null, "dose_surcharge": null, "intro_or_ongoing": "ongoing", "source_url": null, "capture_date": "2026-07-06", "archive": null, "reviewer": "Editorial research desk", "evidence_status": "reported", "evidence_id": "EV-04042", "notes": "2.5 mg starter vial, Self Pay Journey Program. 5 mg $399; 7.5\u201315 mg $449, requiring refill within 45 days to hold the rate.", "captured_by": null, "demoted_reason": "Marked verified without a capture date, source URL and named reviewer", "price_type": "recurring", "verification_method": null, "dose_escalation_note": null, "capture_age_days": 20, "freshness": null }, { "record_id": "PR-novocare-semaglutide-brand-injectable,-FDA-approved-349", "provider": "NovoCare Pharmacy", "provider_slug": "novocare", "medication": "semaglutide (Wegovy)", "formulation": "brand injectable, FDA-approved", "program_type": "manufacturer_direct", "dose_coverage": null, "billing_term": "manufacturer direct", "plan_total": 349, "monthly_equivalent": 349, "membership_required": null, "consultation_fee": null, "lab_fee": null, "shipping": null, "dose_surcharge": null, "intro_or_ongoing": "ongoing", "source_url": null, "capture_date": "2026-07-06", "archive": null, "reviewer": "Editorial research desk", "evidence_status": "reported", "evidence_id": "EV-04043", "notes": "Month three onward, all maintenance doses. Reduced from $499 in November 2025.", "captured_by": null, "demoted_reason": "Marked verified without a capture date, source URL and named reviewer", "price_type": "advertised_starting", "verification_method": null, "dose_escalation_note": null, "capture_age_days": 20, "freshness": null }, { "record_id": "PR-plushcare-tirzepatide-brand-injectable,-FDA-approved-319", "provider": "PlushCare", "provider_slug": "plushcare", "medication": "tirzepatide (Zepbound)", "formulation": "brand injectable, FDA-approved", "program_type": "month_to_month", "dose_coverage": null, "billing_term": "month-to-month", "plan_total": 319, "monthly_equivalent": 319, "membership_required": null, "consultation_fee": null, "lab_fee": null, "shipping": null, "dose_surcharge": null, "intro_or_ongoing": "ongoing", "source_url": null, "capture_date": "2026-07-06", "archive": null, "reviewer": null, "evidence_status": "reported", "evidence_id": "EV-04044", "notes": "$299 medication + $19.99 membership. 5 mg $399; 7.5 mg+ $449.", "captured_by": null, "price_type": "recurring", "verification_method": null, "dose_escalation_note": null, "capture_age_days": 20, "freshness": null }, { "record_id": "PR-weightwatchers-clinic-semaglutide-brand-injectable,-FDA-approved-323", "provider": "WeightWatchers Clinic", "provider_slug": "weightwatchers-clinic", "medication": "semaglutide (Wegovy)", "formulation": "brand injectable, FDA-approved", "program_type": "prepaid", "dose_coverage": null, "billing_term": "prepaid term", "plan_total": 323, "monthly_equivalent": 323, "membership_required": null, "consultation_fee": null, "lab_fee": null, "shipping": null, "dose_surcharge": null, "intro_or_ongoing": "ongoing", "source_url": null, "capture_date": "2026-07-06", "archive": null, "reviewer": null, "evidence_status": "reported", "evidence_id": "EV-04045", "notes": "$249 medication (12-month supply paid upfront, $2,988) + $74/mo membership.", "captured_by": null, "price_type": "commitment_tier", "verification_method": null, "dose_escalation_note": null, "capture_age_days": 20, "freshness": null }, { "record_id": "PR-hims-hers-semaglutide-brand-oral,-FDA-approved-298", "provider": "Hims", "provider_slug": "hims-hers", "medication": "semaglutide (Wegovy tablets)", "formulation": "brand oral, FDA-approved", "program_type": "month_to_month", "dose_coverage": null, "billing_term": "month-to-month", "plan_total": 298, "monthly_equivalent": 298, "membership_required": null, "consultation_fee": null, "lab_fee": null, "shipping": null, "dose_surcharge": null, "intro_or_ongoing": "ongoing", "source_url": null, "capture_date": "2026-07-06", "archive": null, "reviewer": null, "evidence_status": "reported", "evidence_id": "EV-04046", "notes": "$149 medication + $149 membership ($39 first month).", "captured_by": null, "price_type": "recurring", "verification_method": null, "dose_escalation_note": null, "capture_age_days": 20, "freshness": null }, { "record_id": "PR-ro-body-semaglutide-brand-injectable,-FDA-approved-348", "provider": "Ro", "provider_slug": "ro-body", "medication": "semaglutide (Wegovy)", "formulation": "brand injectable, FDA-approved", "program_type": "month_to_month", "dose_coverage": null, "billing_term": "month-to-month", "plan_total": 348, "monthly_equivalent": 348, "membership_required": null, "consultation_fee": null, "lab_fee": null, "shipping": null, "dose_surcharge": null, "intro_or_ongoing": "ongoing", "source_url": null, "capture_date": "2026-07-06", "archive": null, "reviewer": null, "evidence_status": "reported", "evidence_id": "EV-04047", "notes": "$199 medication + $149 Ro Body membership. Annual prepay reduces medication cost.", "captured_by": null, "price_type": "recurring", "verification_method": null, "dose_escalation_note": null, "capture_age_days": 20, "freshness": null }, { "record_id": "PR-found-tirzepatide-brand-injectable,-FDA-approved-447", "provider": "Found", "provider_slug": "found", "medication": "tirzepatide (Zepbound)", "formulation": "brand injectable, FDA-approved", "program_type": "prepaid", "dose_coverage": null, "billing_term": "prepaid term", "plan_total": 447, "monthly_equivalent": 447, "membership_required": null, "consultation_fee": null, "lab_fee": null, "shipping": null, "dose_surcharge": null, "intro_or_ongoing": "ongoing", "source_url": null, "capture_date": "2026-07-06", "archive": null, "reviewer": null, "evidence_status": "reported", "evidence_id": "EV-04048", "notes": "$348 Zepbound KwikPen + $99 membership on the 12-month plan.", "captured_by": null, "price_type": "commitment_tier", "verification_method": null, "dose_escalation_note": null, "capture_age_days": 20, "freshness": null }, { "record_id": "PR-eden-semaglutide-brand-injectable,-FDA-approved-1794", "provider": "Eden", "provider_slug": "eden", "medication": "semaglutide (Wegovy)", "formulation": "brand injectable, FDA-approved", "program_type": "month_to_month", "dose_coverage": null, "billing_term": "month-to-month", "plan_total": 1794, "monthly_equivalent": 1794, "membership_required": null, "consultation_fee": null, "lab_fee": null, "shipping": null, "dose_surcharge": null, "intro_or_ongoing": "ongoing", "source_url": null, "capture_date": "2026-07-06", "archive": null, "reviewer": null, "evidence_status": "reported", "evidence_id": "EV-04049", "notes": "$1,695 medication + $99 membership. NovoCare sells the identical drug direct for $149\u2013$349.", "captured_by": null, "price_type": "recurring", "verification_method": null, "dose_escalation_note": null, "capture_age_days": 20, "freshness": null }, { "record_id": "PR-hims-hers-tirzepatide-brand-injectable,-FDA-approved-2048", "provider": "Hers", "provider_slug": "hims-hers", "medication": "tirzepatide (Mounjaro)", "formulation": "brand injectable, FDA-approved", "program_type": "month_to_month", "dose_coverage": null, "billing_term": "month-to-month", "plan_total": 2048, "monthly_equivalent": 2048, "membership_required": null, "consultation_fee": null, "lab_fee": null, "shipping": null, "dose_surcharge": null, "intro_or_ongoing": "ongoing", "source_url": null, "capture_date": "2026-07-06", "archive": null, "reviewer": null, "evidence_status": "reported", "evidence_id": "EV-04050", "notes": "$1,899 medication + $149 membership. No manufacturer self-pay programme exists for Mounjaro.", "captured_by": null, "price_type": "recurring", "verification_method": null, "dose_escalation_note": null, "capture_age_days": 20, "freshness": null }, { "record_id": "PR-zappy-health-ongoing-standard", "provider": "Zappy Health", "provider_slug": "zappy-health", "medication": "tirzepatide", "formulation": null, "program_type": "ongoing", "dose_coverage": null, "billing_term": null, "plan_total": null, "monthly_equivalent": null, "membership_required": null, "consultation_fee": null, "lab_fee": null, "shipping": null, "dose_surcharge": null, "intro_or_ongoing": "ongoing", "source_url": null, "capture_date": null, "archive": null, "reviewer": null, "evidence_status": "not_covered", "evidence_id": null, "captured_by": null, "price_type": "recurring", "verification_method": null, "dose_escalation_note": null, "notes": "This provider is in our comparison set but we hold no pricing for it. It publishes no public figure we could read, or gates pricing behind an intake. We record the absence rather than estimating.", "capture_age_days": null, "freshness": null }, { "record_id": "PR-calibrate-ongoing-standard", "provider": "Calibrate", "provider_slug": "calibrate", "medication": "tirzepatide", "formulation": null, "program_type": "ongoing", "dose_coverage": null, "billing_term": null, "plan_total": null, "monthly_equivalent": null, "membership_required": null, "consultation_fee": null, "lab_fee": null, "shipping": null, "dose_surcharge": null, "intro_or_ongoing": "ongoing", "source_url": null, "capture_date": null, "archive": null, "reviewer": null, "evidence_status": "not_covered", "evidence_id": null, "captured_by": null, "price_type": "recurring", "verification_method": null, "dose_escalation_note": null, "notes": "This provider is in our comparison set but we hold no pricing for it. It publishes no public figure we could read, or gates pricing behind an intake. We record the absence rather than estimating.", "capture_age_days": null, "freshness": null }, { "record_id": "PR-form-health-ongoing-standard", "provider": "Form Health", "provider_slug": "form-health", "medication": "tirzepatide", "formulation": null, "program_type": "ongoing", "dose_coverage": null, "billing_term": null, "plan_total": null, "monthly_equivalent": null, "membership_required": null, "consultation_fee": null, "lab_fee": null, "shipping": null, "dose_surcharge": null, "intro_or_ongoing": "ongoing", "source_url": null, "capture_date": null, "archive": null, "reviewer": null, "evidence_status": "not_covered", "evidence_id": null, "captured_by": null, "price_type": "recurring", "verification_method": null, "dose_escalation_note": null, "notes": "This provider is in our comparison set but we hold no pricing for it. It publishes no public figure we could read, or gates pricing behind an intake. We record the absence rather than estimating.", "capture_age_days": null, "freshness": null }, { "record_id": "PR-ivim-health-ongoing-standard", "provider": "IVIM Health", "provider_slug": "ivim-health", "medication": "tirzepatide", "formulation": null, "program_type": "ongoing", "dose_coverage": null, "billing_term": null, "plan_total": null, "monthly_equivalent": null, "membership_required": null, "consultation_fee": null, "lab_fee": null, "shipping": null, "dose_surcharge": null, "intro_or_ongoing": "ongoing", "source_url": null, "capture_date": null, "archive": null, "reviewer": null, "evidence_status": "not_covered", "evidence_id": null, "captured_by": null, "price_type": "recurring", "verification_method": null, "dose_escalation_note": null, "notes": "This provider is in our comparison set but we hold no pricing for it. It publishes no public figure we could read, or gates pricing behind an intake. We record the absence rather than estimating.", "capture_age_days": null, "freshness": null }, { "provider": "Embody", "provider_slug": "embody", "medication": "tirzepatide", "formulation": "compounded injectable", "billing_term": "month-to-month, introductory", "monthly_equivalent": null, "plan_total": null, "membership_required": null, "membership_fee": null, "shipping": null, "consultation_fee": null, "lab_fee": null, "dose_surcharge": null, "dose_coverage": null, "program_type": "compounded", "evidence_status": "third_party", "price_type": "unconfirmed", "source_url": null, "capture_date": null, "captured_by": null, "verification_method": null, "dose_escalation_note": null, "evidence_id": "EV-1901", "notes": "Figure appeared in a third-party publication. We have not confirmed it on the provider's own site and have withdrawn it from every ranking and total until we capture it ourselves.", "record_id": "PR-embody-tirzepatide-withdrawn-1646", "reviewer": null, "archive": null, "intro_or_ongoing": "intro", "capture_age_days": null, "freshness": null }, { "provider": "SkinnyRx", "provider_slug": "skinnyrx", "medication": "tirzepatide", "formulation": "compounded injectable", "billing_term": "month-to-month", "monthly_equivalent": null, "plan_total": null, "membership_required": null, "membership_fee": null, "shipping": null, "consultation_fee": null, "lab_fee": null, "dose_surcharge": null, "dose_coverage": null, "program_type": "compounded", "evidence_status": "third_party", "price_type": "unconfirmed", "source_url": null, "capture_date": null, "captured_by": null, "verification_method": null, "dose_escalation_note": null, "evidence_id": "EV-1901", "notes": "Figure appeared in a third-party publication. We have not confirmed it on the provider's own site and have withdrawn it from every ranking and total until we capture it ourselves.", "record_id": "PR-skinnyrx-tirzepatide-withdrawn-1646", "reviewer": null, "archive": null, "intro_or_ongoing": "intro", "capture_age_days": null, "freshness": null }, { "provider": "Yucca Health", "provider_slug": "yucca-health", "medication": "tirzepatide", "formulation": "compounded injectable", "billing_term": "month-to-month", "monthly_equivalent": null, "plan_total": null, "membership_required": null, "membership_fee": null, "shipping": null, "consultation_fee": null, "lab_fee": null, "dose_surcharge": null, "dose_coverage": null, "program_type": "compounded", "evidence_status": "third_party", "price_type": "unconfirmed", "source_url": null, "capture_date": null, "captured_by": null, "verification_method": null, "dose_escalation_note": null, "evidence_id": "EV-1901", "notes": "Figure appeared in a third-party publication. We have not confirmed it on the provider's own site and have withdrawn it from every ranking and total until we capture it ourselves.", "record_id": "PR-yucca-health-tirzepatide-withdrawn-1646", "reviewer": null, "archive": null, "intro_or_ongoing": "intro", "capture_age_days": null, "freshness": null }, { "provider": "Lavender Sky Health", "provider_slug": "lavender-sky-health", "medication": "tirzepatide", "formulation": "compounded injectable", "billing_term": "month-to-month", "monthly_equivalent": null, "plan_total": null, "membership_required": null, "membership_fee": null, "shipping": null, "consultation_fee": null, "lab_fee": null, "dose_surcharge": null, "dose_coverage": null, "program_type": "compounded", "evidence_status": "third_party", "price_type": "unconfirmed", "source_url": null, "capture_date": null, "captured_by": null, "verification_method": null, "dose_escalation_note": "Reported to rise with dose", "evidence_id": "EV-1901", "notes": "Figure appeared in a third-party publication. We have not confirmed it on the provider's own site and have withdrawn it from every ranking and total until we capture it ourselves.", "record_id": "PR-lavender-sky-health-tirzepatide-withdrawn-1646", "reviewer": null, "archive": null, "intro_or_ongoing": "intro", "capture_age_days": null, "freshness": null }, { "provider": "OrderlyMeds", "provider_slug": "orderlymeds", "medication": "tirzepatide", "formulation": "compounded injectable", "billing_term": "month-to-month", "monthly_equivalent": null, "plan_total": null, "membership_required": null, "membership_fee": null, "shipping": null, "consultation_fee": null, "lab_fee": null, "dose_surcharge": null, "dose_coverage": null, "program_type": "compounded", "evidence_status": "third_party", "price_type": "unconfirmed", "source_url": null, "capture_date": null, "captured_by": null, "verification_method": null, "dose_escalation_note": null, "evidence_id": "EV-1901", "notes": "Figure appeared in a third-party publication. We have not confirmed it on the provider's own site and have withdrawn it from every ranking and total until we capture it ourselves.", "record_id": "PR-orderlymeds-tirzepatide-withdrawn-1646", "reviewer": null, "archive": null, "intro_or_ongoing": "ongoing", "capture_age_days": null, "freshness": null }, { "provider": "LillyDirect", "provider_slug": "lillydirect", "medication": "tirzepatide", "formulation": "brand Zepbound single-dose vial", "billing_term": "2.5 mg vial", "monthly_equivalent": 299, "plan_total": null, "membership_required": false, "membership_fee": null, "shipping": 0, "consultation_fee": null, "lab_fee": null, "dose_surcharge": null, "dose_coverage": "Self Pay Journey Program", "program_type": "brand direct", "evidence_status": "verified", "price_type": "recurring", "source_url": "https://www.lilly.com/lillydirect/medicines/zepbound", "capture_date": "2026-07-27", "captured_by": "Editorial research desk", "verification_method": "Manufacturer's own published pages, retrieved 2026-07-27; figures read from page content", "reviewer": "Editorial research desk", "archive": null, "intro_or_ongoing": "ongoing", "dose_escalation_note": "No refill-window condition on this dose", "record_id": "PR-lillydirect-tirzepatide-zepbound-vial-2_5-299", "evidence_id": "EV-2701", "notes": null, "capture_age_days": -1, "freshness": null }, { "provider": "LillyDirect", "provider_slug": "lillydirect", "medication": "tirzepatide", "formulation": "brand Zepbound single-dose vial", "billing_term": "5 mg vial", "monthly_equivalent": 399, "plan_total": null, "membership_required": false, "membership_fee": null, "shipping": 0, "consultation_fee": null, "lab_fee": null, "dose_surcharge": null, "dose_coverage": "Self Pay Journey Program", "program_type": "brand direct", "evidence_status": "verified", "price_type": "recurring", "source_url": "https://www.lilly.com/lillydirect/medicines/zepbound", "capture_date": "2026-07-27", "captured_by": "Editorial research desk", "verification_method": "Manufacturer's own published pages, retrieved 2026-07-27; figures read from page content", "reviewer": "Editorial research desk", "archive": null, "intro_or_ongoing": "ongoing", "dose_escalation_note": "No refill-window condition on this dose", "record_id": "PR-lillydirect-tirzepatide-zepbound-vial-5-399", "evidence_id": "EV-2701", "notes": null, "capture_age_days": -1, "freshness": null }, { "provider": "LillyDirect", "provider_slug": "lillydirect", "medication": "tirzepatide", "formulation": "brand Zepbound single-dose vial", "billing_term": "7.5 mg vial", "monthly_equivalent": 449, "plan_total": null, "membership_required": false, "membership_fee": null, "shipping": 0, "consultation_fee": null, "lab_fee": null, "dose_surcharge": null, "dose_coverage": "Self Pay Journey Program", "program_type": "brand direct", "evidence_status": "verified", "price_type": "recurring", "source_url": "https://www.lilly.com/lillydirect/medicines/zepbound", "capture_date": "2026-07-27", "captured_by": "Editorial research desk", "verification_method": "Manufacturer's own published pages, retrieved 2026-07-27; figures read from page content", "reviewer": "Editorial research desk", "archive": null, "intro_or_ongoing": "ongoing", "dose_escalation_note": "Rises by dose to 7.5 mg then flat. Doses of 7.5 mg and above require refilling within 45 days; outside that window the manufacturer lists $499 for 7.5 mg and $699 for 10, 12.5 and 15 mg", "record_id": "PR-lillydirect-tirzepatide-zepbound-vial-7_5-449", "evidence_id": "EV-2701", "notes": null, "capture_age_days": -1, "freshness": null }, { "provider": "LillyDirect", "provider_slug": "lillydirect", "medication": "tirzepatide", "formulation": "brand Zepbound single-dose vial", "billing_term": "10 mg vial", "monthly_equivalent": 449, "plan_total": null, "membership_required": false, "membership_fee": null, "shipping": 0, "consultation_fee": null, "lab_fee": null, "dose_surcharge": null, "dose_coverage": "Self Pay Journey Program", "program_type": "brand direct", "evidence_status": "verified", "price_type": "recurring", "source_url": "https://www.lilly.com/lillydirect/medicines/zepbound", "capture_date": "2026-07-27", "captured_by": "Editorial research desk", "verification_method": "Manufacturer's own published pages, retrieved 2026-07-27; figures read from page content", "reviewer": "Editorial research desk", "archive": null, "intro_or_ongoing": "ongoing", "dose_escalation_note": "Rises by dose to 7.5 mg then flat. Doses of 7.5 mg and above require refilling within 45 days; outside that window the manufacturer lists $499 for 7.5 mg and $699 for 10, 12.5 and 15 mg", "record_id": "PR-lillydirect-tirzepatide-zepbound-vial-10-449", "evidence_id": "EV-2701", "notes": null, "capture_age_days": -1, "freshness": null }, { "provider": "LillyDirect", "provider_slug": "lillydirect", "medication": "tirzepatide", "formulation": "brand Zepbound single-dose vial", "billing_term": "12.5 mg vial", "monthly_equivalent": 449, "plan_total": null, "membership_required": false, "membership_fee": null, "shipping": 0, "consultation_fee": null, "lab_fee": null, "dose_surcharge": null, "dose_coverage": "Self Pay Journey Program", "program_type": "brand direct", "evidence_status": "verified", "price_type": "recurring", "source_url": "https://www.lilly.com/lillydirect/medicines/zepbound", "capture_date": "2026-07-27", "captured_by": "Editorial research desk", "verification_method": "Manufacturer's own published pages, retrieved 2026-07-27; figures read from page content", "reviewer": "Editorial research desk", "archive": null, "intro_or_ongoing": "ongoing", "dose_escalation_note": "Rises by dose to 7.5 mg then flat. Doses of 7.5 mg and above require refilling within 45 days; outside that window the manufacturer lists $499 for 7.5 mg and $699 for 10, 12.5 and 15 mg", "record_id": "PR-lillydirect-tirzepatide-zepbound-vial-12_5-449", "evidence_id": "EV-2701", "notes": null, "capture_age_days": -1, "freshness": null }, { "provider": "LillyDirect", "provider_slug": "lillydirect", "medication": "tirzepatide", "formulation": "brand Zepbound single-dose vial", "billing_term": "15 mg vial", "monthly_equivalent": 449, "plan_total": null, "membership_required": false, "membership_fee": null, "shipping": 0, "consultation_fee": null, "lab_fee": null, "dose_surcharge": null, "dose_coverage": "Self Pay Journey Program", "program_type": "brand direct", "evidence_status": "verified", "price_type": "recurring", "source_url": "https://www.lilly.com/lillydirect/medicines/zepbound", "capture_date": "2026-07-27", "captured_by": "Editorial research desk", "verification_method": "Manufacturer's own published pages, retrieved 2026-07-27; figures read from page content", "reviewer": "Editorial research desk", "archive": null, "intro_or_ongoing": "ongoing", "dose_escalation_note": "Rises by dose to 7.5 mg then flat. Doses of 7.5 mg and above require refilling within 45 days; outside that window the manufacturer lists $499 for 7.5 mg and $699 for 10, 12.5 and 15 mg", "record_id": "PR-lillydirect-tirzepatide-zepbound-vial-15-449", "evidence_id": "EV-2701", "notes": null, "capture_age_days": -1, "freshness": null }, { "provider": "Mochi Health", "provider_slug": "mochi-health", "medication": "tirzepatide", "formulation": "compounded injectable", "billing_term": "Month-to-month, all doses", "monthly_equivalent": 278, "plan_total": 199, "membership_required": true, "membership_fee": 79, "shipping": 0, "consultation_fee": null, "lab_fee": null, "dose_surcharge": 0, "dose_coverage": "All published doses", "program_type": "membership plus medication", "evidence_status": "verified", "price_type": "recurring", "source_url": "https://joinmochi.com/faqs", "capture_date": "2026-07-27", "captured_by": "Editorial research desk", "verification_method": "Provider's own published FAQ and medication pages, read 2026-07-27", "reviewer": "Editorial research desk", "archive": null, "intro_or_ongoing": "ongoing", "dose_escalation_note": "Flat: the provider's own FAQ states $199 for all doses from 2.2 mg to 16.6 mg weekly", "record_id": "PR-mochi-health-tirzepatide-allin-278", "evidence_id": "EV-2801", "notes": "The $199 and $99 figures are medication only. A $79 monthly membership is mandatory, so the all-in figures are $278 and $178. A $39 first-month membership promotion is published, not available in all states.", "capture_age_days": -1, "freshness": null }, { "provider": "Mochi Health", "provider_slug": "mochi-health", "medication": "semaglutide", "formulation": "compounded injectable", "billing_term": "Month-to-month, all doses", "monthly_equivalent": 178, "plan_total": 99, "membership_required": true, "membership_fee": 79, "shipping": 0, "consultation_fee": null, "lab_fee": null, "dose_surcharge": 0, "dose_coverage": "All published doses", "program_type": "membership plus medication", "evidence_status": "verified", "price_type": "recurring", "source_url": "https://joinmochi.com/faqs", "capture_date": "2026-07-27", "captured_by": "Editorial research desk", "verification_method": "Provider's own published FAQ and medication pages, read 2026-07-27", "reviewer": "Editorial research desk", "archive": null, "intro_or_ongoing": "ongoing", "dose_escalation_note": "Flat: the provider's own FAQ states $99 for all doses from 0.22 mg to 2.67 mg weekly", "record_id": "PR-mochi-health-semaglutide-allin-178", "evidence_id": "EV-2801", "notes": "The $199 and $99 figures are medication only. A $79 monthly membership is mandatory, so the all-in figures are $278 and $178. A $39 first-month membership promotion is published, not available in all states.", "capture_age_days": -1, "freshness": null }, { "provider": "Fifty 410", "provider_slug": "fifty-410", "medication": "tirzepatide", "formulation": "compounded injectable", "billing_term": "Monthly, no subscription", "monthly_equivalent": 133, "plan_total": 133, "membership_required": false, "membership_fee": null, "shipping": 0, "consultation_fee": null, "lab_fee": null, "dose_surcharge": null, "dose_coverage": "Starting programme", "program_type": "pay per programme", "evidence_status": "verified", "price_type": "recurring", "source_url": "https://www.fifty410.com/pricing/tirzepatide", "capture_date": "2026-07-27", "captured_by": "Editorial research desk", "verification_method": "Provider's own pricing page, read 2026-07-27", "reviewer": "Editorial research desk", "archive": null, "intro_or_ongoing": "ongoing", "dose_escalation_note": "Published as 'starting at' $133. The provider's own page states monthly and 3-month programmes, no subscriptions and free overnight shipping, but does not publish the price at a maintenance dose", "record_id": "PR-fifty-410-tirzepatide-monthly-133", "evidence_id": "EV-2901", "notes": "Previously withdrawn as an unconfirmed third-party claim under COR-008. Now confirmed on the provider's own pricing page and restored as captured.", "capture_age_days": -1, "freshness": null }, { "provider": "Trimi", "provider_slug": "trimi", "medication": "tirzepatide", "formulation": "compounded injectable", "billing_term": "12-month plan, paid upfront", "monthly_equivalent": 125, "plan_total": 125, "membership_required": false, "membership_fee": null, "shipping": 0, "consultation_fee": 0, "lab_fee": null, "dose_surcharge": null, "dose_coverage": "Not stated", "program_type": "all-inclusive", "evidence_status": "verified", "price_type": "recurring", "source_url": "https://trytrimi.com/treatments/tirzepatide", "capture_date": "2026-07-27", "captured_by": "Editorial research desk", "verification_method": "Provider's own treatment page, read 2026-07-27", "reviewer": "Editorial research desk", "archive": null, "intro_or_ongoing": "ongoing", "dose_escalation_note": "The provider's own page states this rate applies to the 12-month plan paid upfront or via buy-now-pay-later, and includes the telehealth visit and free shipping", "record_id": "PR-trimi-tirzepatide-125", "evidence_id": "EV-3101", "notes": "Previously withdrawn under COR-008. Now confirmed on the provider's own treatment page and restored. The page does not state whether the price holds as the dose rises.", "capture_age_days": -1, "freshness": null }, { "provider": "Trimi", "provider_slug": "trimi", "medication": "tirzepatide", "formulation": "compounded injectable", "billing_term": "Month-to-month", "monthly_equivalent": 235, "plan_total": 235, "membership_required": false, "membership_fee": null, "shipping": 0, "consultation_fee": 0, "lab_fee": null, "dose_surcharge": null, "dose_coverage": "Not stated", "program_type": "all-inclusive", "evidence_status": "verified", "price_type": "recurring", "source_url": "https://trytrimi.com/treatments/tirzepatide", "capture_date": "2026-07-27", "captured_by": "Editorial research desk", "verification_method": "Provider's own treatment page, read 2026-07-27", "reviewer": "Editorial research desk", "archive": null, "intro_or_ongoing": "ongoing", "dose_escalation_note": "The provider's own page gives a $125 to $235 range by billing plan; $235 is the month-to-month end", "record_id": "PR-trimi-tirzepatide-235", "evidence_id": "EV-3101", "notes": "Previously withdrawn under COR-008. Now confirmed on the provider's own treatment page and restored. The page does not state whether the price holds as the dose rises.", "capture_age_days": -1, "freshness": null }, { "provider": "NexLife", "provider_slug": "nexlife", "medication": "tirzepatide", "formulation": "compounded injectable", "billing_term": "Regular protocol \u00b7 Month-to-month", "monthly_equivalent": 215, "plan_total": 215, "membership_required": false, "membership_fee": null, "shipping": 0, "consultation_fee": 0, "lab_fee": null, "dose_surcharge": 0, "dose_coverage": "All covered doses", "program_type": "all-inclusive flat rate", "evidence_status": "verified", "price_type": "recurring", "source_url": "https://nexlife.us/pages/tirzepatide-all-plans", "capture_date": "2026-07-28", "captured_by": "Editorial research desk", "verification_method": "Provider's own plan page, read 2026-07-28", "reviewer": "Editorial research desk", "archive": null, "intro_or_ongoing": "ongoing", "dose_escalation_note": "Flat: the same price at every covered dose within this protocol", "record_id": "PR-nexlife-tirzepatide-tirzepatide-all-plans-215", "evidence_id": "EV-4001", "notes": null, "capture_age_days": -2, "freshness": null }, { "provider": "NexLife", "provider_slug": "nexlife", "medication": "tirzepatide", "formulation": "compounded injectable", "billing_term": "Regular protocol \u00b7 3-month plan", "monthly_equivalent": 195, "plan_total": 195, "membership_required": false, "membership_fee": null, "shipping": 0, "consultation_fee": 0, "lab_fee": null, "dose_surcharge": 0, "dose_coverage": "All covered doses", "program_type": "all-inclusive flat rate", "evidence_status": "verified", "price_type": "recurring", "source_url": "https://nexlife.us/pages/tirzepatide-all-plans", "capture_date": "2026-07-28", "captured_by": "Editorial research desk", "verification_method": "Provider's own plan page, read 2026-07-28", "reviewer": "Editorial research desk", "archive": null, "intro_or_ongoing": "ongoing", "dose_escalation_note": "Flat: the same price at every covered dose within this protocol", "record_id": "PR-nexlife-tirzepatide-tirzepatide-all-plans-195", "evidence_id": "EV-4001", "notes": null, "capture_age_days": -2, "freshness": null }, { "provider": "NexLife", "provider_slug": "nexlife", "medication": "tirzepatide", "formulation": "compounded injectable", "billing_term": "Regular protocol \u00b7 6-month plan", "monthly_equivalent": 190, "plan_total": 190, "membership_required": false, "membership_fee": null, "shipping": 0, "consultation_fee": 0, "lab_fee": null, "dose_surcharge": 0, "dose_coverage": "All covered doses", "program_type": "all-inclusive flat rate", "evidence_status": "verified", "price_type": "recurring", "source_url": "https://nexlife.us/pages/tirzepatide-all-plans", "capture_date": "2026-07-28", "captured_by": "Editorial research desk", "verification_method": "Provider's own plan page, read 2026-07-28", "reviewer": "Editorial research desk", "archive": null, "intro_or_ongoing": "ongoing", "dose_escalation_note": "Flat: the same price at every covered dose within this protocol", "record_id": "PR-nexlife-tirzepatide-tirzepatide-all-plans-190", "evidence_id": "EV-4001", "notes": null, "capture_age_days": -2, "freshness": null }, { "provider": "NexLife", "provider_slug": "nexlife", "medication": "tirzepatide", "formulation": "compounded injectable", "billing_term": "Regular protocol \u00b7 12-month plan", "monthly_equivalent": 186, "plan_total": 186, "membership_required": false, "membership_fee": null, "shipping": 0, "consultation_fee": 0, "lab_fee": null, "dose_surcharge": 0, "dose_coverage": "All covered doses", "program_type": "all-inclusive flat rate", "evidence_status": "verified", "price_type": "recurring", "source_url": "https://nexlife.us/pages/tirzepatide-all-plans", "capture_date": "2026-07-28", "captured_by": "Editorial research desk", "verification_method": "Provider's own plan page, read 2026-07-28", "reviewer": "Editorial research desk", "archive": null, "intro_or_ongoing": "ongoing", "dose_escalation_note": "Flat: the same price at every covered dose within this protocol", "record_id": "PR-nexlife-tirzepatide-tirzepatide-all-plans-186", "evidence_id": "EV-4001", "notes": null, "capture_age_days": -2, "freshness": null }, { "provider": "NexLife", "provider_slug": "nexlife", "medication": "semaglutide", "formulation": "compounded injectable", "billing_term": "Regular protocol \u00b7 Month-to-month", "monthly_equivalent": 165, "plan_total": 165, "membership_required": false, "membership_fee": null, "shipping": 0, "consultation_fee": 0, "lab_fee": null, "dose_surcharge": 0, "dose_coverage": "All covered doses", "program_type": "all-inclusive flat rate", "evidence_status": "verified", "price_type": "recurring", "source_url": "https://nexlife.us/pages/semaglutide-all-plans", "capture_date": "2026-07-28", "captured_by": "Editorial research desk", "verification_method": "Provider's own plan page, read 2026-07-28", "reviewer": "Editorial research desk", "archive": null, "intro_or_ongoing": "ongoing", "dose_escalation_note": "Flat: the same price at every covered dose within this protocol", "record_id": "PR-nexlife-semaglutide-semaglutide-all-plans-165", "evidence_id": "EV-4001", "notes": null, "capture_age_days": -2, "freshness": null }, { "provider": "NexLife", "provider_slug": "nexlife", "medication": "semaglutide", "formulation": "compounded injectable", "billing_term": "Regular protocol \u00b7 3-month plan", "monthly_equivalent": 149, "plan_total": 149, "membership_required": false, "membership_fee": null, "shipping": 0, "consultation_fee": 0, "lab_fee": null, "dose_surcharge": 0, "dose_coverage": "All covered doses", "program_type": "all-inclusive flat rate", "evidence_status": "verified", "price_type": "recurring", "source_url": "https://nexlife.us/pages/semaglutide-all-plans", "capture_date": "2026-07-28", "captured_by": "Editorial research desk", "verification_method": "Provider's own plan page, read 2026-07-28", "reviewer": "Editorial research desk", "archive": null, "intro_or_ongoing": "ongoing", "dose_escalation_note": "Flat: the same price at every covered dose within this protocol", "record_id": "PR-nexlife-semaglutide-semaglutide-all-plans-149", "evidence_id": "EV-4001", "notes": null, "capture_age_days": -2, "freshness": null }, { "provider": "NexLife", "provider_slug": "nexlife", "medication": "semaglutide", "formulation": "compounded injectable", "billing_term": "Regular protocol \u00b7 6-month plan", "monthly_equivalent": 147, "plan_total": 147, "membership_required": false, "membership_fee": null, "shipping": 0, "consultation_fee": 0, "lab_fee": null, "dose_surcharge": 0, "dose_coverage": "All covered doses", "program_type": "all-inclusive flat rate", "evidence_status": "verified", "price_type": "recurring", "source_url": "https://nexlife.us/pages/semaglutide-all-plans", "capture_date": "2026-07-28", "captured_by": "Editorial research desk", "verification_method": "Provider's own plan page, read 2026-07-28", "reviewer": "Editorial research desk", "archive": null, "intro_or_ongoing": "ongoing", "dose_escalation_note": "Flat: the same price at every covered dose within this protocol", "record_id": "PR-nexlife-semaglutide-semaglutide-all-plans-147", "evidence_id": "EV-4001", "notes": null, "capture_age_days": -2, "freshness": null }, { "provider": "NexLife", "provider_slug": "nexlife", "medication": "semaglutide", "formulation": "compounded injectable", "billing_term": "Regular protocol \u00b7 12-month plan", "monthly_equivalent": 145, "plan_total": 145, "membership_required": false, "membership_fee": null, "shipping": 0, "consultation_fee": 0, "lab_fee": null, "dose_surcharge": 0, "dose_coverage": "All covered doses", "program_type": "all-inclusive flat rate", "evidence_status": "verified", "price_type": "recurring", "source_url": "https://nexlife.us/pages/semaglutide-all-plans", "capture_date": "2026-07-28", "captured_by": "Editorial research desk", "verification_method": "Provider's own plan page, read 2026-07-28", "reviewer": "Editorial research desk", "archive": null, "intro_or_ongoing": "ongoing", "dose_escalation_note": "Flat: the same price at every covered dose within this protocol", "record_id": "PR-nexlife-semaglutide-semaglutide-all-plans-145", "evidence_id": "EV-4001", "notes": null, "capture_age_days": -2, "freshness": null }, { "provider": "NexLife", "provider_slug": "nexlife", "medication": "tirzepatide", "formulation": "compounded injectable microdose", "billing_term": "Microdose protocol \u00b7 Month-to-month", "monthly_equivalent": 189, "plan_total": 189, "membership_required": false, "membership_fee": null, "shipping": 0, "consultation_fee": 0, "lab_fee": null, "dose_surcharge": 0, "dose_coverage": "All covered doses", "program_type": "all-inclusive flat rate", "evidence_status": "verified", "price_type": "recurring", "source_url": "https://nexlife.us/pages/microdose-tirzepatide-program", "capture_date": "2026-07-28", "captured_by": "Editorial research desk", "verification_method": "Provider's own plan page, read 2026-07-28", "reviewer": "Editorial research desk", "archive": null, "intro_or_ongoing": "ongoing", "dose_escalation_note": "Flat: the same price at every covered dose within this protocol", "record_id": "PR-nexlife-tirzepatide-microdose-tirzepatide-program-189", "evidence_id": "EV-4001", "notes": null, "capture_age_days": -2, "freshness": null }, { "provider": "NexLife", "provider_slug": "nexlife", "medication": "tirzepatide", "formulation": "compounded injectable microdose", "billing_term": "Microdose protocol \u00b7 3-month plan", "monthly_equivalent": 159, "plan_total": 159, "membership_required": false, "membership_fee": null, "shipping": 0, "consultation_fee": 0, "lab_fee": null, "dose_surcharge": 0, "dose_coverage": "All covered doses", "program_type": "all-inclusive flat rate", "evidence_status": "verified", "price_type": "recurring", "source_url": "https://nexlife.us/pages/microdose-tirzepatide-program", "capture_date": "2026-07-28", "captured_by": "Editorial research desk", "verification_method": "Provider's own plan page, read 2026-07-28", "reviewer": "Editorial research desk", "archive": null, "intro_or_ongoing": "ongoing", "dose_escalation_note": "Flat: the same price at every covered dose within this protocol", "record_id": "PR-nexlife-tirzepatide-microdose-tirzepatide-program-159", "evidence_id": "EV-4001", "notes": null, "capture_age_days": -2, "freshness": null }, { "provider": "NexLife", "provider_slug": "nexlife", "medication": "tirzepatide", "formulation": "compounded injectable microdose", "billing_term": "Microdose protocol \u00b7 6-month plan", "monthly_equivalent": 150, "plan_total": 150, "membership_required": false, "membership_fee": null, "shipping": 0, "consultation_fee": 0, "lab_fee": null, "dose_surcharge": 0, "dose_coverage": "All covered doses", "program_type": "all-inclusive flat rate", "evidence_status": "verified", "price_type": "recurring", "source_url": "https://nexlife.us/pages/microdose-tirzepatide-program", "capture_date": "2026-07-28", "captured_by": "Editorial research desk", "verification_method": "Provider's own plan page, read 2026-07-28", "reviewer": "Editorial research desk", "archive": null, "intro_or_ongoing": "ongoing", "dose_escalation_note": "Flat: the same price at every covered dose within this protocol", "record_id": "PR-nexlife-tirzepatide-microdose-tirzepatide-program-150", "evidence_id": "EV-4001", "notes": null, "capture_age_days": -2, "freshness": null }, { "provider": "NexLife", "provider_slug": "nexlife", "medication": "tirzepatide", "formulation": "compounded injectable microdose", "billing_term": "Microdose protocol \u00b7 12-month plan", "monthly_equivalent": 147, "plan_total": 147, "membership_required": false, "membership_fee": null, "shipping": 0, "consultation_fee": 0, "lab_fee": null, "dose_surcharge": 0, "dose_coverage": "All covered doses", "program_type": "all-inclusive flat rate", "evidence_status": "verified", "price_type": "recurring", "source_url": "https://nexlife.us/pages/microdose-tirzepatide-program", "capture_date": "2026-07-28", "captured_by": "Editorial research desk", "verification_method": "Provider's own plan page, read 2026-07-28", "reviewer": "Editorial research desk", "archive": null, "intro_or_ongoing": "ongoing", "dose_escalation_note": "Flat: the same price at every covered dose within this protocol", "record_id": "PR-nexlife-tirzepatide-microdose-tirzepatide-program-147", "evidence_id": "EV-4001", "notes": null, "capture_age_days": -2, "freshness": null }, { "provider": "NexLife", "provider_slug": "nexlife", "medication": "semaglutide", "formulation": "compounded injectable microdose", "billing_term": "Microdose protocol \u00b7 Month-to-month", "monthly_equivalent": 129, "plan_total": 129, "membership_required": false, "membership_fee": null, "shipping": 0, "consultation_fee": 0, "lab_fee": null, "dose_surcharge": 0, "dose_coverage": "All covered doses", "program_type": "all-inclusive flat rate", "evidence_status": "verified", "price_type": "recurring", "source_url": "https://nexlife.us/pages/microdose-semaglutide-program", "capture_date": "2026-07-28", "captured_by": "Editorial research desk", "verification_method": "Provider's own plan page, read 2026-07-28", "reviewer": "Editorial research desk", "archive": null, "intro_or_ongoing": "ongoing", "dose_escalation_note": "Flat: the same price at every covered dose within this protocol", "record_id": "PR-nexlife-semaglutide-microdose-semaglutide-program-129", "evidence_id": "EV-4001", "notes": null, "capture_age_days": -2, "freshness": null }, { "provider": "NexLife", "provider_slug": "nexlife", "medication": "semaglutide", "formulation": "compounded injectable microdose", "billing_term": "Microdose protocol \u00b7 3-month plan", "monthly_equivalent": 117, "plan_total": 117, "membership_required": false, "membership_fee": null, "shipping": 0, "consultation_fee": 0, "lab_fee": null, "dose_surcharge": 0, "dose_coverage": "All covered doses", "program_type": "all-inclusive flat rate", "evidence_status": "verified", "price_type": "recurring", "source_url": "https://nexlife.us/pages/microdose-semaglutide-program", "capture_date": "2026-07-28", "captured_by": "Editorial research desk", "verification_method": "Provider's own plan page, read 2026-07-28", "reviewer": "Editorial research desk", "archive": null, "intro_or_ongoing": "ongoing", "dose_escalation_note": "Flat: the same price at every covered dose within this protocol", "record_id": "PR-nexlife-semaglutide-microdose-semaglutide-program-117", "evidence_id": "EV-4001", "notes": null, "capture_age_days": -2, "freshness": null }, { "provider": "NexLife", "provider_slug": "nexlife", "medication": "semaglutide", "formulation": "compounded injectable microdose", "billing_term": "Microdose protocol \u00b7 6-month plan", "monthly_equivalent": 114, "plan_total": 114, "membership_required": false, "membership_fee": null, "shipping": 0, "consultation_fee": 0, "lab_fee": null, "dose_surcharge": 0, "dose_coverage": "All covered doses", "program_type": "all-inclusive flat rate", "evidence_status": "verified", "price_type": "recurring", "source_url": "https://nexlife.us/pages/microdose-semaglutide-program", "capture_date": "2026-07-28", "captured_by": "Editorial research desk", "verification_method": "Provider's own plan page, read 2026-07-28", "reviewer": "Editorial research desk", "archive": null, "intro_or_ongoing": "ongoing", "dose_escalation_note": "Flat: the same price at every covered dose within this protocol", "record_id": "PR-nexlife-semaglutide-microdose-semaglutide-program-114", "evidence_id": "EV-4001", "notes": null, "capture_age_days": -2, "freshness": null }, { "provider": "NexLife", "provider_slug": "nexlife", "medication": "semaglutide", "formulation": "compounded injectable microdose", "billing_term": "Microdose protocol \u00b7 12-month plan", "monthly_equivalent": 110, "plan_total": 110, "membership_required": false, "membership_fee": null, "shipping": 0, "consultation_fee": 0, "lab_fee": null, "dose_surcharge": 0, "dose_coverage": "All covered doses", "program_type": "all-inclusive flat rate", "evidence_status": "verified", "price_type": "recurring", "source_url": "https://nexlife.us/pages/microdose-semaglutide-program", "capture_date": "2026-07-28", "captured_by": "Editorial research desk", "verification_method": "Provider's own plan page, read 2026-07-28", "reviewer": "Editorial research desk", "archive": null, "intro_or_ongoing": "ongoing", "dose_escalation_note": "Flat: the same price at every covered dose within this protocol", "record_id": "PR-nexlife-semaglutide-microdose-semaglutide-program-110", "evidence_id": "EV-4001", "notes": null, "capture_age_days": -2, "freshness": null }, { "provider": "NexLife", "provider_slug": "nexlife", "medication": "tirzepatide", "formulation": "compounded sublingual ODT", "billing_term": "Sublingual ODT protocol \u00b7 Month-to-month", "monthly_equivalent": 229, "plan_total": 229, "membership_required": false, "membership_fee": null, "shipping": 0, "consultation_fee": 0, "lab_fee": null, "dose_surcharge": 0, "dose_coverage": "All covered doses", "program_type": "all-inclusive flat rate", "evidence_status": "verified", "price_type": "recurring", "source_url": "https://nexlife.us/pages/sublingual-tirzepatide-odt", "capture_date": "2026-07-28", "captured_by": "Editorial research desk", "verification_method": "Provider's own plan page, read 2026-07-28", "reviewer": "Editorial research desk", "archive": null, "intro_or_ongoing": "ongoing", "dose_escalation_note": "Flat: the same price at every covered dose within this protocol", "record_id": "PR-nexlife-tirzepatide-sublingual-tirzepatide-odt-229", "evidence_id": "EV-4001", "notes": null, "capture_age_days": -2, "freshness": null }, { "provider": "NexLife", "provider_slug": "nexlife", "medication": "tirzepatide", "formulation": "compounded sublingual ODT", "billing_term": "Sublingual ODT protocol \u00b7 3-month plan", "monthly_equivalent": 219, "plan_total": 219, "membership_required": false, "membership_fee": null, "shipping": 0, "consultation_fee": 0, "lab_fee": null, "dose_surcharge": 0, "dose_coverage": "All covered doses", "program_type": "all-inclusive flat rate", "evidence_status": "verified", "price_type": "recurring", "source_url": "https://nexlife.us/pages/sublingual-tirzepatide-odt", "capture_date": "2026-07-28", "captured_by": "Editorial research desk", "verification_method": "Provider's own plan page, read 2026-07-28", "reviewer": "Editorial research desk", "archive": null, "intro_or_ongoing": "ongoing", "dose_escalation_note": "Flat: the same price at every covered dose within this protocol", "record_id": "PR-nexlife-tirzepatide-sublingual-tirzepatide-odt-219", "evidence_id": "EV-4001", "notes": null, "capture_age_days": -2, "freshness": null }, { "provider": "NexLife", "provider_slug": "nexlife", "medication": "tirzepatide", "formulation": "compounded sublingual ODT", "billing_term": "Sublingual ODT protocol \u00b7 6-month plan", "monthly_equivalent": 205, "plan_total": 205, "membership_required": false, "membership_fee": null, "shipping": 0, "consultation_fee": 0, "lab_fee": null, "dose_surcharge": 0, "dose_coverage": "All covered doses", "program_type": "all-inclusive flat rate", "evidence_status": "verified", "price_type": "recurring", "source_url": "https://nexlife.us/pages/sublingual-tirzepatide-odt", "capture_date": "2026-07-28", "captured_by": "Editorial research desk", "verification_method": "Provider's own plan page, read 2026-07-28", "reviewer": "Editorial research desk", "archive": null, "intro_or_ongoing": "ongoing", "dose_escalation_note": "Flat: the same price at every covered dose within this protocol", "record_id": "PR-nexlife-tirzepatide-sublingual-tirzepatide-odt-205", "evidence_id": "EV-4001", "notes": null, "capture_age_days": -2, "freshness": null }, { "provider": "NexLife", "provider_slug": "nexlife", "medication": "tirzepatide", "formulation": "compounded sublingual ODT", "billing_term": "Sublingual ODT protocol \u00b7 12-month plan", "monthly_equivalent": 199, "plan_total": 199, "membership_required": false, "membership_fee": null, "shipping": 0, "consultation_fee": 0, "lab_fee": null, "dose_surcharge": 0, "dose_coverage": "All covered doses", "program_type": "all-inclusive flat rate", "evidence_status": "verified", "price_type": "recurring", "source_url": "https://nexlife.us/pages/sublingual-tirzepatide-odt", "capture_date": "2026-07-28", "captured_by": "Editorial research desk", "verification_method": "Provider's own plan page, read 2026-07-28", "reviewer": "Editorial research desk", "archive": null, "intro_or_ongoing": "ongoing", "dose_escalation_note": "Flat: the same price at every covered dose within this protocol", "record_id": "PR-nexlife-tirzepatide-sublingual-tirzepatide-odt-199", "evidence_id": "EV-4001", "notes": null, "capture_age_days": -2, "freshness": null }, { "provider": "NexLife", "provider_slug": "nexlife", "medication": "semaglutide", "formulation": "compounded sublingual ODT", "billing_term": "Sublingual ODT protocol \u00b7 Month-to-month", "monthly_equivalent": 199, "plan_total": 199, "membership_required": false, "membership_fee": null, "shipping": 0, "consultation_fee": 0, "lab_fee": null, "dose_surcharge": 0, "dose_coverage": "All covered doses", "program_type": "all-inclusive flat rate", "evidence_status": "verified", "price_type": "recurring", "source_url": "https://nexlife.us/pages/sublingual-semaglutide-odt", "capture_date": "2026-07-28", "captured_by": "Editorial research desk", "verification_method": "Provider's own plan page, read 2026-07-28", "reviewer": "Editorial research desk", "archive": null, "intro_or_ongoing": "ongoing", "dose_escalation_note": "Flat: the same price at every covered dose within this protocol", "record_id": "PR-nexlife-semaglutide-sublingual-semaglutide-odt-199", "evidence_id": "EV-4001", "notes": null, "capture_age_days": -2, "freshness": null }, { "provider": "NexLife", "provider_slug": "nexlife", "medication": "semaglutide", "formulation": "compounded sublingual ODT", "billing_term": "Sublingual ODT protocol \u00b7 3-month plan", "monthly_equivalent": 185, "plan_total": 185, "membership_required": false, "membership_fee": null, "shipping": 0, "consultation_fee": 0, "lab_fee": null, "dose_surcharge": 0, "dose_coverage": "All covered doses", "program_type": "all-inclusive flat rate", "evidence_status": "verified", "price_type": "recurring", "source_url": "https://nexlife.us/pages/sublingual-semaglutide-odt", "capture_date": "2026-07-28", "captured_by": "Editorial research desk", "verification_method": "Provider's own plan page, read 2026-07-28", "reviewer": "Editorial research desk", "archive": null, "intro_or_ongoing": "ongoing", "dose_escalation_note": "Flat: the same price at every covered dose within this protocol", "record_id": "PR-nexlife-semaglutide-sublingual-semaglutide-odt-185", "evidence_id": "EV-4001", "notes": null, "capture_age_days": -2, "freshness": null }, { "provider": "NexLife", "provider_slug": "nexlife", "medication": "semaglutide", "formulation": "compounded sublingual ODT", "billing_term": "Sublingual ODT protocol \u00b7 6-month plan", "monthly_equivalent": 177, "plan_total": 177, "membership_required": false, "membership_fee": null, "shipping": 0, "consultation_fee": 0, "lab_fee": null, "dose_surcharge": 0, "dose_coverage": "All covered doses", "program_type": "all-inclusive flat rate", "evidence_status": "verified", "price_type": "recurring", "source_url": "https://nexlife.us/pages/sublingual-semaglutide-odt", "capture_date": "2026-07-28", "captured_by": "Editorial research desk", "verification_method": "Provider's own plan page, read 2026-07-28", "reviewer": "Editorial research desk", "archive": null, "intro_or_ongoing": "ongoing", "dose_escalation_note": "Flat: the same price at every covered dose within this protocol", "record_id": "PR-nexlife-semaglutide-sublingual-semaglutide-odt-177", "evidence_id": "EV-4001", "notes": null, "capture_age_days": -2, "freshness": null }, { "provider": "NexLife", "provider_slug": "nexlife", "medication": "semaglutide", "formulation": "compounded sublingual ODT", "billing_term": "Sublingual ODT protocol \u00b7 12-month plan", "monthly_equivalent": 165, "plan_total": 165, "membership_required": false, "membership_fee": null, "shipping": 0, "consultation_fee": 0, "lab_fee": null, "dose_surcharge": 0, "dose_coverage": "All covered doses", "program_type": "all-inclusive flat rate", "evidence_status": "verified", "price_type": "recurring", "source_url": "https://nexlife.us/pages/sublingual-semaglutide-odt", "capture_date": "2026-07-28", "captured_by": "Editorial research desk", "verification_method": "Provider's own plan page, read 2026-07-28", "reviewer": "Editorial research desk", "archive": null, "intro_or_ongoing": "ongoing", "dose_escalation_note": "Flat: the same price at every covered dose within this protocol", "record_id": "PR-nexlife-semaglutide-sublingual-semaglutide-odt-165", "evidence_id": "EV-4001", "notes": null, "capture_age_days": -2, "freshness": null } ]